Addressing Health Disparities in the Care of NSCLC: Patient Case Discussions
Released On
May 9, 2023
Expires On
May 9, 2024
Media Type
Internet
Completion Time
30 minutes
Specialty
Pathology, Primary Care, Radiology
Topic(s)
Lung Cancer, Oncology, Pharmacology, Radiology
This activity is jointly provided by Postgraduate Institute for Medicine and Catamount Medical Education.
This activity is supported by independent educational grants from Merck Sharp & Dohme, LLC, and Novocure Inc.
Credit Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of medical oncologists, pathologists, interventional radiologists, pharmacists, nurse practitioners, PAs, and nurses involved with the care of patients with NSCLC.
Statement of Need/Program Overview
A focused online module that examines health disparities in the treatment of patients with NSCLC, and the use of strategies and best practices to address these disparities.
Learning Objectives
After completing this activity, the participant should be better able to:
- Review evidence of health disparities in the care of patients with NSCLC
- Discuss population-specific barriers to standards of care for patients with NSCLC
- Utilize strategies to address disparities in the care of patients with NSCLC
Faculty
Narjust Florez, MD
Associate Director of the Cancer Care Equity Program
Thoracic Oncologist – Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine,
Harvard Medical School
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Catamount Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Physician Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
- Narjust Florez, MD
- Consultant/Advisory Board: AstraZeneca, DSI, Janssen Scientific Affairs, LLC, Merck Sharp & Dohme, LLC, Mirati, Neogenomics, Pfizer, Regeneron
The PIM planners and others have nothing to disclose. The Catamount Medical Education planners and others have nothing to disclose.
Instructions for Participation and Credit
This activity is an online enduring material. There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CME information, completing the pretest, viewing the video, studying the educational activity, and completing the posttest and the evaluation form. Upon completion of the evaluation, your certificate will be made available immediately. Click on "View Certificate" and print the certificate for your records.
This activity was originally released on May 9, 2023, and is eligible for credit through May 9, 2024
Course Viewing Requirements
This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.
Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
Our Policy
When you participate in a CME activity provided by the Postgraduate Institute for Medicine (“PIM” or “we”), we ask you for your name, degree, affiliation, street address, telephone number, fax number, and e-mail address (the “Information”). We use that Information in the following ways:
We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
We may use the Information to invite you to participate in other CME activities that PIM or its affiliates may offer.
On occasion, the commercial supporter of a CME activity will ask us for a list of the people who participated in that activity, so that it may document the first level of outcomes-based evaluation in CME (i.e., who attended, which medical specialties/practices were represented, how this compares to the target audience, and whether the activity needs to be repeated because significant numbers of the target audience did not attend). In that event, we will provide the supporter with your name, title and affiliation, but we will request in writing that the supporter not contact you directly for any purpose.
If our company is acquired or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
Any changes to our privacy policy will be posted here immediately.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Contact Information
For questions about this activity, please contact Catamount Medical Education at [email protected].